InsidersTradesSigma
UFP Technologies INC Stock: price and insider trades · United States · SEC (Form 4)
Track the UFP Technologies INC stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, UFP Technologies INC has logged 164 insider filings. Market capitalisation: €2.1bn. The latest transaction was filed on 8 June 2026 (Attribution). Among the most active insiders: BAILLY R JEFFREY. Every trade is openly available.
164
Insider Decl.
0
Thresholds
€241,249
5 ops.
Buy Volume
€28m
44 ops.
Sell Volume
52Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 11,418 of 25,791 companies
55.0
score / 100
Value46
Quality64
FCF yld3.9%
Earn yld3.3%
EV/EBITDA19.7x
ROE17%
Gross mgn28%
Net mgn11%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 June 2026
Declarations164 total
1,787 shares0Common Stock, $.01 Par ValueSEC:0002084956-26-000048:0
750 shares@ US$223.870.0072% mcap0.5% of flowCommon Stock, $.01 Par ValueSEC:0002084956-26-000048:1
802 shares0Common Stock, $.01 Par ValueSEC:0002084956-26-000037:0
802 shares0Common Stock, $.01 Par ValueSEC:0002084956-26-000038:0
2,864 shares@ US$221.710.032% mcap45.6% of flowCommon Stock, $.01 Par ValueSEC:0002084956-26-000026:0
2,864 shares@ US$221.710.032% mcap45.6% of flowCommon Stock, $.01 Par ValueSEC:0002084956-26-000026
2,921 shares@ US$19.973.5% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-009371:0
1,429 shares@ US$220.0819.5% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-009127:0
623 shares@ US$215.2429.4% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004699:0
9,805 shares@ US$215.247.3% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004691:0
2,034 shares@ US$215.249.4% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004692:0
462 shares@ US$215.2421.9% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004702:0
2,756 shares@ US$38.6124.7% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004478:0
2,523 shares@ US$215.2430.2% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004693:0
921 shares@ US$215.2413.3% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004694:0
661 shares@ US$225.7010.7% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004167:0
400 shares@ US$229.08992.0% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-003779:0
Ideal exit: 24 Nov 2025 (T+270)
571 shares0Common Stock, $.01 Par ValueSEC:0001062993-25-002209:0
2,141 shares0Common Stock, $.01 Par ValueSEC:0001062993-25-002202:0
10,140 shares0Common Stock, $.01 Par ValueSEC:0001062993-25-002201:0
2,515 shares0Common Stock, $.01 Par ValueSEC:0001062993-25-002204:0
571 shares0Common Stock, $.01 Par ValueSEC:0001062993-25-002210:0
877 shares0Common Stock, $.01 Par ValueSEC:0001062993-25-002207:0
1,582 shares0Common Stock, $.01 Par ValueSEC:0001062993-24-021197:0
8,773 shares@ US$345.1010.2% of flowCommon Stock, $.01 Par ValueSEC:0001062993-24-019133:0
25 of 164 declarations
About UFP Technologies INC
UFP Technologies, Inc. is a US-based industrial healthcare manufacturing company listed on the NASDAQ under the ticker UFPT. Headquartered in Newburyport, Massachusetts, United States, the company was founded in 1963 and has evolved from a protective packaging business into a specialized contract development and manufacturing organization. Today, it focuses primarily on single-use and single-patient medical devices, making it a niche supplier within the medical technology supply chain rather than a broad-based diversified manufacturer. The company’s core business centers on design, engineering, and manufacturing solutions for the medical market. Its products and components are used in minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. In practical terms, UFP Technologies acts as an outsourcing partner to major medical-device OEMs, helping customers move from concept and design through industrialization, production, and delivery. This model tends to support sticky customer relationships, recurring program revenue, and a value proposition based on technical know-how rather than pure price competition. From a competitive standpoint, UFP Technologies benefits from specialization, application engineering, and a multi-site manufacturing footprint. The company describes itself as an important link in the medical-device supply chain and a valued outsourcing partner to many of the world’s leading medical-device manufacturers. That positioning creates meaningful barriers to entry, especially where customers require validated processes, materials expertise, regulatory discipline, and reliable transfer of production across facilities. Recent developments have been positive and strategically relevant. In 2025, UFP Technologies reported record full-year results, with strong growth in revenue and net income, and it continued to expand through targeted acquisitions. Management also highlighted new program launches and additional manufacturing capacity to support future growth. In early 2026, the company reported another solid quarter and said its recent acquisitions were performing well, with integrations essentially complete. Another key event for investors is leadership transition: the company announced that CEO R. Jeffrey Bailly is scheduled to retire at the annual meeting on June 4, 2026. For investors following Form 4 insider transactions, that combination of growth, acquisition activity, and succession planning is especially important to monitor.
